AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE

AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE was reported 1259 times

AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED HAEMOGLOBINOPATHY 1 0.2000
1 IMPLANTABLE CARDIAC MONITOR REPLACEMENT 1 0.1429
2 HEPATITIS D RNA POSITIVE 1 0.1111
3 URINARY ASCITES 1 0.0476
4 BLOOD PRESSURE ORTHOSTATIC INCREASED 1 0.0400
5 FREE PROSTATE-SPECIFIC ANTIGEN INCREASED 1 0.0357
6 RED BLOOD CELL BURR CELLS PRESENT 1 0.0222
7 MEDICAL DEVICE SITE BRUISE 1 0.0147
8 WEIGHT LOSS DIET 1 0.0135
9 HEART ALTERNATION 1 0.0125
10 TONGUE ROUGH 1 0.0118
11 HAEMORRHAGIC HEPATIC CYST 1 0.0105
12 AORTIC EMBOLUS 1 0.0104
13 BACILLUS BACTERAEMIA 1 0.0092
14 ANTI-GAD ANTIBODY POSITIVE 1 0.0089
15 MEDICAL DEVICE SITE EROSION 1 0.0083
16 COAGULATION FACTOR V LEVEL ABNORMAL 1 0.0081
17 SENILE OSTEOPOROSIS 1 0.0081
18 LABORATORY TEST 1 0.0074
19 GENITAL BLISTER 2 0.0072
20 POUCHITIS 6 0.0070
21 BOREDOM 2 0.0059
22 DEAFNESS PERMANENT 1 0.0051
23 PANCREATIC OPERATION 1 0.0046
24 PRODUCT INTOLERANCE 1 0.0045
25 NECROTISING SOFT TISSUE INFECTION 1 0.0043
26 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
27 MECHANICAL URTICARIA 2 0.0043
28 MARITAL PROBLEM 2 0.0037
29 DUODENOGASTRIC REFLUX 1 0.0036
30 SECONDARY HYPERTENSION 1 0.0035
31 ALLERGY TO VACCINE 1 0.0032
32 RENAL VASCULITIS 1 0.0031
33 BREAST HAEMORRHAGE 1 0.0030
34 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
35 PRODUCT CLOSURE REMOVAL DIFFICULT 3 0.0029
36 STASIS DERMATITIS 2 0.0029
37 HYPERALDOSTERONISM 1 0.0029
38 ANION GAP DECREASED 1 0.0029
39 HEART SOUNDS ABNORMAL 2 0.0027
40 MYASTHENIC SYNDROME 2 0.0026
41 BLUE TOE SYNDROME 1 0.0026
42 FAECAL CALPROTECTIN INCREASED 8 0.0025
43 HOUSEBOUND 1 0.0025
44 DISEASE RISK FACTOR 1 0.0025
45 PRODUCT SUBSTITUTION 1 0.0025
46 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
47 PERINEAL ABSCESS 1 0.0022
48 CERUMEN IMPACTION 2 0.0022
49 SALIVARY GLAND DISORDER 1 0.0021
50 NORMOCYTIC ANAEMIA 3 0.0020
51 ELECTROLYTE DEPLETION 1 0.0020
52 BLEPHARAL PIGMENTATION 1 0.0020
53 PRODUCT CONTAMINATION 7 0.0020
54 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
55 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
56 FRACTURE OF PENIS 1 0.0019
57 INTRAOCULAR PRESSURE DECREASED 1 0.0019
58 INSTILLATION SITE ERYTHEMA 1 0.0019
59 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
60 PRODUCT COMMINGLING 2 0.0019
61 GINGIVAL DISCOLOURATION 1 0.0019
62 WHITE COAT HYPERTENSION 1 0.0018
63 PRODUCT ODOUR ABNORMAL 19 0.0018
64 GENITAL DISCOMFORT 1 0.0018
65 BLOOD SODIUM DECREASED 34 0.0018
66 CARDIORENAL SYNDROME 1 0.0017
67 OESOPHAGEAL IRRITATION 1 0.0017
68 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
69 CELLULITIS ORBITAL 1 0.0017
70 WRIST DEFORMITY 1 0.0016
71 BLOOD BILIRUBIN DECREASED 1 0.0016
72 NIPPLE DISORDER 1 0.0016
73 POOR VENOUS ACCESS 16 0.0015
74 PNEUMOCOCCAL SEPSIS 1 0.0015
75 BONE OPERATION 1 0.0015
76 COMPULSIONS 1 0.0015
77 NASAL OPERATION 1 0.0015
78 POOR QUALITY DRUG ADMINISTERED 9 0.0014
79 BLOOD FOLATE DECREASED 1 0.0014
80 OESOPHAGEAL DISCOMFORT 1 0.0013
81 CREATINE KINASE INCREASED 1 0.0013
82 DRUG TOLERANCE INCREASED 1 0.0013
83 INGROWING NAIL 3 0.0013
84 GROWTH OF EYELASHES 1 0.0013
85 RENAL HAEMANGIOMA 1 0.0013
86 CHOROIDAL EFFUSION 1 0.0012
87 VASCULAR ACCESS COMPLICATION 1 0.0012
88 KETONURIA 1 0.0012
89 BODY TEMPERATURE DECREASED 12 0.0012
90 TONGUE ERYTHEMA 1 0.0012
91 URGE INCONTINENCE 1 0.0011
92 BLOOD ALBUMIN INCREASED 1 0.0011
93 MUSCLE SWELLING 1 0.0011
94 BLOOD UREA ABNORMAL 1 0.0011
95 THERAPEUTIC RESPONSE INCREASED 1 0.0011
96 RED BLOOD CELL ABNORMALITY 1 0.0010
97 OCULAR HYPERTENSION 2 0.0010
98 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
99 EYE COLOUR CHANGE 1 0.0010
100 PRODUCT COATING ISSUE 1 0.0010
101 SKIN SENSITISATION 1 0.0010
102 NASAL INFLAMMATION 1 0.0009
103 BONE DEMINERALISATION 1 0.0009
104 PANCREATIC MASS 1 0.0009
105 RENAL TUBULAR ACIDOSIS 2 0.0009
106 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
107 DEAFNESS NEUROSENSORY 3 0.0009
108 CHOLESTATIC LIVER INJURY 2 0.0009
109 RHEUMATOID FACTOR INCREASED 1 0.0009
110 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
111 BLOOD URIC ACID INCREASED 5 0.0009
112 DEFAECATION URGENCY 6 0.0009
113 HYPOCHLORAEMIA 1 0.0009
114 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
115 APPENDICECTOMY 3 0.0008
116 URINE FLOW DECREASED 2 0.0008
117 HYPONATRAEMIA 47 0.0008
118 PROSTATIC OPERATION 1 0.0008
119 BLEEDING TIME PROLONGED 1 0.0008
120 MONOCYTE COUNT DECREASED 1 0.0008
121 BLADDER PROLAPSE 1 0.0008
122 VESTIBULAR DISORDER 1 0.0008
123 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
124 VICTIM OF CRIME 1 0.0008
125 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
126 APPLICATION SITE SCAR 1 0.0008
127 SEROMA 1 0.0008
128 CAROTID ARTERY DISEASE 1 0.0008
129 ANAL INCONTINENCE 7 0.0008
130 DACRYOSTENOSIS ACQUIRED 1 0.0008
131 BILIARY OBSTRUCTION 1 0.0008
132 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
133 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
134 PROTEIN TOTAL INCREASED 2 0.0008
135 GAMBLING DISORDER 2 0.0007
136 SKIN WRINKLING 2 0.0007
137 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
138 CLUSTER HEADACHE 1 0.0007
139 GOUT 13 0.0007
140 INFLAMMATORY BOWEL DISEASE 7 0.0007
141 AUDITORY DISORDER 1 0.0007
142 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
143 BLOOD CREATINE INCREASED 3 0.0007
144 CONJUNCTIVITIS ALLERGIC 1 0.0007
145 URINE ANALYSIS ABNORMAL 2 0.0007
146 BLOOD PRESSURE INADEQUATELY CONTROLLED 4 0.0007
147 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
148 HYPERKALAEMIA 23 0.0007
149 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
150 OSTEOMALACIA 1 0.0006
151 EYE ALLERGY 1 0.0006
152 INAPPROPRIATE AFFECT 1 0.0006
153 NASAL ULCER 1 0.0006
154 AORTIC VALVE DISEASE 1 0.0006
155 SYSTEMIC INFECTION 1 0.0006
156 PROSTATE CANCER METASTATIC 2 0.0006
157 POTENTIATING DRUG INTERACTION 2 0.0006
158 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1 0.0006
159 DEAFNESS BILATERAL 1 0.0006
160 MICTURITION DISORDER 2 0.0006
161 SPLENIC INFARCTION 1 0.0006
162 VERTIGO POSITIONAL 1 0.0006
163 DISEASE RECURRENCE 27 0.0006
164 KYPHOSIS 1 0.0006
165 TERMINAL INSOMNIA 1 0.0006
166 SINUS NODE DYSFUNCTION 1 0.0005
167 PNEUMONIA KLEBSIELLA 1 0.0005
168 SNORING 2 0.0005
169 PARANASAL SINUS DISCOMFORT 2 0.0005
170 ALCOHOL INTERACTION 1 0.0005
171 EARLY SATIETY 1 0.0005
172 HYPOVOLAEMIA 3 0.0005
173 HYPOGEUSIA 1 0.0005
174 EMPYEMA 1 0.0005
175 HEARING IMPAIRED 3 0.0005
176 BLOOD POTASSIUM DECREASED 15 0.0005
177 VITAMIN B12 DEFICIENCY 2 0.0005
178 HYPERPARATHYROIDISM 1 0.0005
179 VENOUS THROMBOSIS LIMB 1 0.0005
180 OLIGURIA 3 0.0005
181 VASCULAR OCCLUSION 1 0.0005
182 PHARYNGEAL ERYTHEMA 1 0.0005
183 BLOOD PRESSURE INCREASED 72 0.0005
184 FOREIGN BODY SENSATION IN EYES 3 0.0005
185 BLOOD TESTOSTERONE INCREASED 1 0.0005
186 CARDIAC FLUTTER 3 0.0005
187 JAW FRACTURE 1 0.0005
188 HORDEOLUM 2 0.0005
189 PULMONARY FUNCTION TEST DECREASED 2 0.0005
190 DIABETIC NEPHROPATHY 1 0.0005
191 CLOSTRIDIUM TEST POSITIVE 1 0.0005
192 PHYSICAL DISABILITY 2 0.0005
193 DANDRUFF 1 0.0005
194 PRODUCT LOT NUMBER ISSUE 1 0.0005
195 WHEELCHAIR USER 2 0.0004
196 HYPERTENSIVE CRISIS 5 0.0004
197 FEAR OF DEATH 1 0.0004
198 VASCULAR DEVICE INFECTION 2 0.0004
199 HAEMATOCRIT INCREASED 1 0.0004
200 END STAGE RENAL DISEASE 8 0.0004
201 EYELID DISORDER 1 0.0004
202 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
203 BREAKTHROUGH PAIN 1 0.0004
204 NEPHROGENIC ANAEMIA 2 0.0004
205 ELECTROLYTE IMBALANCE 5 0.0004
206 DISCOURAGEMENT 1 0.0004
207 VOLVULUS 1 0.0004
208 URINARY HESITATION 1 0.0004
209 OXYGEN CONSUMPTION INCREASED 1 0.0004
210 GASTROINTESTINAL OBSTRUCTION 1 0.0004
211 PULSE ABNORMAL 1 0.0004
212 PRODUCT DISPENSING ERROR 9 0.0004
213 SELF ESTEEM DECREASED 1 0.0004
214 HYPOKALAEMIA 19 0.0004
215 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
216 BRONCHITIS CHRONIC 1 0.0004
217 INCORRECT DOSAGE ADMINISTERED 2 0.0004
218 DERMAL CYST 1 0.0004
219 SPRUE-LIKE ENTEROPATHY 2 0.0004
220 CARTILAGE INJURY 1 0.0004
221 BLOOD PRESSURE ABNORMAL 8 0.0004
222 DRUG TOLERANCE 2 0.0004
223 DYSPHORIA 2 0.0004
224 AMMONIA INCREASED 2 0.0004
225 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
226 BLOOD CHLORIDE DECREASED 1 0.0004
227 RETINAL DISORDER 1 0.0004
228 HEPATITIS TOXIC 1 0.0004
229 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
230 RADICULOPATHY 1 0.0004
231 BLOOD POTASSIUM INCREASED 6 0.0004
232 CHONDROPATHY 1 0.0004
233 ABDOMINAL RIGIDITY 1 0.0004
234 POLYURIA 3 0.0004
235 BLOOD PHOSPHORUS INCREASED 1 0.0004
236 APPLICATION SITE HAEMORRHAGE 1 0.0004
237 JAW DISORDER 2 0.0004
238 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
239 RED BLOOD CELL COUNT INCREASED 1 0.0004
240 PROSTATIC DISORDER 2 0.0004
241 VITREOUS HAEMORRHAGE 1 0.0004
242 BLOOD TEST ABNORMAL 5 0.0004
243 OXYGEN SATURATION ABNORMAL 1 0.0004
244 IMPAIRED DRIVING ABILITY 4 0.0004
245 OESOPHAGEAL STENOSIS 1 0.0004
246 ERECTILE DYSFUNCTION 9 0.0004
247 DYSPNOEA AT REST 1 0.0003
248 HAEMOTHORAX 1 0.0003
249 URINE OUTPUT DECREASED 3 0.0003
250 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
251 LUMBAR SPINAL STENOSIS 1 0.0003
252 NECK INJURY 1 0.0003
253 CREPITATIONS 1 0.0003
254 FREQUENT BOWEL MOVEMENTS 9 0.0003
255 REBOUND ACID HYPERSECRETION 1 0.0003
256 PORTAL HYPERTENSION 1 0.0003
257 BLOOD CREATININE INCREASED 21 0.0003
258 PRE-EXISTING CONDITION IMPROVED 2 0.0003
259 SECRETION DISCHARGE 4 0.0003
260 FOREIGN BODY IN THROAT 1 0.0003
261 BREAST CANCER RECURRENT 1 0.0003
262 DRUG EFFECT INCREASED 1 0.0003
263 NON-CARDIAC CHEST PAIN 1 0.0003
264 BLOOD PRESSURE DECREASED 21 0.0003
265 DIZZINESS POSTURAL 3 0.0003
266 VITAMIN D DEFICIENCY 3 0.0003
267 POLYP 2 0.0003
268 THROMBOSIS IN DEVICE 1 0.0003
269 INCORRECT PRODUCT STORAGE 4 0.0003
270 INFUSION SITE HAEMORRHAGE 1 0.0003
271 INABILITY TO AFFORD MEDICATION 3 0.0003
272 PRESCRIBED UNDERDOSE 6 0.0003
273 ANXIETY DISORDER 1 0.0003
274 BLOOD UREA INCREASED 5 0.0003
275 WOUND DEHISCENCE 1 0.0003
276 PRODUCT TASTE ABNORMAL 4 0.0003
277 REGURGITATION 1 0.0003
278 TEMPERATURE INTOLERANCE 3 0.0003
279 BLOOD CREATININE ABNORMAL 1 0.0003
280 HYPOTENSION 58 0.0003
281 EYE DISCHARGE 3 0.0003
282 PRESYNCOPE 7 0.0003
283 ORTHOSTATIC HYPOTENSION 5 0.0003
284 EMBOLIC STROKE 1 0.0003
285 NECROTISING FASCIITIS 1 0.0003
286 HEAD DISCOMFORT 5 0.0003
287 GLOSSITIS 1 0.0003
288 APPARENT DEATH 1 0.0003
289 TONGUE DISORDER 2 0.0003
290 LIVER TRANSPLANT 1 0.0003
291 RESTLESS LEGS SYNDROME 5 0.0003
292 CUTANEOUS VASCULITIS 1 0.0003
293 INTENTIONAL UNDERDOSE 2 0.0003
294 BLOOD PHOSPHORUS DECREASED 1 0.0003
295 THROMBOCYTOSIS 1 0.0003
296 HYPERACUSIS 1 0.0003
297 HYPERTENSION 56 0.0003
298 ECONOMIC PROBLEM 4 0.0003
299 POLLAKIURIA 11 0.0003
300 COMMUNICATION DISORDER 1 0.0003
301 THYROID DISORDER 4 0.0003
302 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
303 EAR PAIN 5 0.0003
304 SPINAL CORD COMPRESSION 1 0.0003
305 MUSCLE RUPTURE 1 0.0003
306 SPINAL PAIN 3 0.0003
307 PROCEDURAL HAEMORRHAGE 1 0.0003
308 PROSTATOMEGALY 1 0.0003
309 DRUG SCREEN POSITIVE 2 0.0003
310 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
311 INTRACRANIAL ANEURYSM 1 0.0002
312 SENSORY LOSS 2 0.0002
313 RHINITIS 2 0.0002
314 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
315 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
316 PERIPHERAL VENOUS DISEASE 1 0.0002
317 TRIGGER FINGER 1 0.0002
318 HYPERURICAEMIA 1 0.0002
319 SPINAL STENOSIS 1 0.0002
320 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
321 RENAL FAILURE 32 0.0002
322 THYROID FUNCTION TEST ABNORMAL 1 0.0002
323 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
324 SUICIDAL BEHAVIOUR 1 0.0002
325 MUSCLE SPASMS 44 0.0002
326 ERECTION INCREASED 1 0.0002
327 SENSATION OF FOREIGN BODY 2 0.0002
328 MUSCLE FATIGUE 1 0.0002
329 ABSCESS LIMB 1 0.0002
330 INTERVERTEBRAL DISC DISORDER 1 0.0002
331 LUNG NEOPLASM 1 0.0002
332 ALCOHOLISM 1 0.0002
333 ROTATOR CUFF SYNDROME 3 0.0002
334 PRODUCT CONTAINER ISSUE 2 0.0002
335 BLOOD MAGNESIUM DECREASED 2 0.0002
336 PSYCHOLOGICAL TRAUMA 2 0.0002
337 RASH GENERALISED 6 0.0002
338 MUSCLE STRAIN 2 0.0002
339 CARDIAC MURMUR 2 0.0002
340 OCULAR ICTERUS 1 0.0002
341 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
342 SYNCOPE 23 0.0002
343 DIVERTICULUM INTESTINAL 1 0.0002
344 BLOOD CALCIUM INCREASED 2 0.0002
345 LIGAMENT RUPTURE 1 0.0002
346 CHRONIC KIDNEY DISEASE 17 0.0002
347 MYOSITIS 2 0.0002
348 HEART RATE INCREASED 22 0.0002
349 HEART RATE IRREGULAR 5 0.0002
350 DRUG EFFECT DELAYED 1 0.0002
351 HAEMOGLOBIN INCREASED 1 0.0002
352 EAR DISORDER 1 0.0002
353 DYSPAREUNIA 1 0.0002
354 DEHYDRATION 29 0.0002
355 DIZZINESS 108 0.0002
356 LOCALISED OEDEMA 1 0.0002
357 RENAL FUNCTION TEST ABNORMAL 1 0.0002
358 RENAL DISORDER 10 0.0002
359 NEPHROPATHY 2 0.0002
360 COLITIS MICROSCOPIC 1 0.0002
361 SLEEP APNOEA SYNDROME 4 0.0002
362 MEDICATION RESIDUE PRESENT 1 0.0002
363 SINUS BRADYCARDIA 2 0.0002
364 RASH VESICULAR 1 0.0002
365 GASTROENTERITIS 3 0.0002
366 DYSSTASIA 6 0.0002
367 HEPATOMEGALY 2 0.0002
368 KNEE OPERATION 2 0.0002
369 APPLICATION SITE BURN 1 0.0002
370 BREATH SOUNDS ABNORMAL 1 0.0002
371 DIABETIC NEUROPATHY 1 0.0002
372 PULMONARY MASS 3 0.0002
373 HYPERNATRAEMIA 1 0.0002
374 VEIN DISORDER 1 0.0002
375 HEART RATE DECREASED 7 0.0002
376 SLUGGISHNESS 2 0.0002
377 ENDOCARDITIS 1 0.0002
378 EAR DISCOMFORT 2 0.0002
379 PRODUCT COLOUR ISSUE 1 0.0002
380 PERIORBITAL OEDEMA 1 0.0002
381 TENDERNESS 2 0.0002
382 LETHARGY 11 0.0002
383 WEIGHT FLUCTUATION 2 0.0002
384 DYSURIA 7 0.0002
385 INCONTINENCE 2 0.0002
386 OBESITY 3 0.0002
387 EATING DISORDER 4 0.0002
388 BREAST PAIN 2 0.0002
389 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
390 FOOD POISONING 1 0.0002
391 ANAL FISSURE 1 0.0002
392 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
393 NIGHT SWEATS 6 0.0002
394 INTESTINAL OBSTRUCTION 7 0.0002
395 DECREASED ACTIVITY 2 0.0002
396 STRESS FRACTURE 1 0.0002
397 SKIN LACERATION 2 0.0002
398 PRODUCT DOSE OMISSION 12 0.0002
399 PRODUCT PRESCRIBING ISSUE 4 0.0002
400 OESOPHAGITIS 2 0.0002
401 ASPIRATION 2 0.0002
402 FAECALOMA 1 0.0002
403 BLOOD GLUCOSE FLUCTUATION 2 0.0002
404 DEAFNESS UNILATERAL 1 0.0002
405 HYPERKERATOSIS 1 0.0002
406 ANGIOEDEMA 8 0.0002
407 FOOT DEFORMITY 2 0.0002
408 TRANSAMINASES INCREASED 4 0.0002
409 INTERMENSTRUAL BLEEDING 1 0.0002
410 TYPE 2 DIABETES MELLITUS 6 0.0002
411 PANCREATITIS ACUTE 4 0.0002
412 INTENTIONAL DOSE OMISSION 5 0.0002
413 MICTURITION URGENCY 2 0.0002
414 CARDIAC VALVE DISEASE 1 0.0002
415 MUSCULOSKELETAL DISCOMFORT 3 0.0002
416 ENTEROCOLITIS 1 0.0002
417 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
418 HYPERVENTILATION 1 0.0002
419 SKIN WARM 1 0.0002
420 URINE ODOUR ABNORMAL 1 0.0002
421 HYPERCHLORHYDRIA 1 0.0002
422 ACUTE KIDNEY INJURY 26 0.0002
423 ENERGY INCREASED 1 0.0002
424 RENAL INJURY 5 0.0002
425 PROTHROMBIN TIME PROLONGED 1 0.0002
426 BLOOD PRESSURE FLUCTUATION 4 0.0002
427 THYROID CANCER 2 0.0002
428 HEPATITIS C 2 0.0002
429 NOCTURIA 2 0.0002
430 FIBROMYALGIA 4 0.0002
431 DERMATITIS ACNEIFORM 1 0.0002
432 LOSS OF CONSCIOUSNESS 21 0.0002
433 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
434 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
435 SCOLIOSIS 1 0.0002
436 THINKING ABNORMAL 3 0.0002
437 HAIR COLOUR CHANGES 2 0.0002
438 VISION BLURRED 22 0.0002
439 INJECTION SITE DISCOLOURATION 2 0.0002
440 INFUSION SITE SWELLING 1 0.0002
441 MUSCLE ATROPHY 2 0.0002
442 PROTEINURIA 3 0.0002
443 HYPOTHYROIDISM 5 0.0002
444 PROCTALGIA 1 0.0002
445 ERUCTATION 3 0.0002
446 RENAL IMPAIRMENT 13 0.0002
447 INCOHERENT 1 0.0002
448 LACTIC ACIDOSIS 5 0.0002
449 APPLICATION SITE VESICLES 1 0.0002
450 HEPATITIS ACUTE 1 0.0002
451 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
452 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
453 SOMNAMBULISM 1 0.0002
454 BEDRIDDEN 2 0.0002
455 ORAL CANDIDIASIS 2 0.0002
456 WALKING AID USER 1 0.0002
457 SINUS DISORDER 3 0.0002
458 CONSTIPATION 33 0.0002
459 ADVERSE REACTION 2 0.0002
460 LIP SWELLING 5 0.0001
461 POST-TRAUMATIC STRESS DISORDER 1 0.0001
462 QUALITY OF LIFE DECREASED 2 0.0001
463 SINUS CONGESTION 2 0.0001
464 PRODUCT LABEL ISSUE 1 0.0001
465 NEUROPATHY PERIPHERAL 14 0.0001
466 GINGIVAL BLEEDING 2 0.0001
467 BLOOD TESTOSTERONE DECREASED 1 0.0001
468 ONYCHOCLASIS 1 0.0001
469 LYMPHOEDEMA 1 0.0001
470 LARGE INTESTINE POLYP 1 0.0001
471 AUTOIMMUNE HEPATITIS 1 0.0001
472 PAPULE 1 0.0001
473 SLEEP DISORDER 10 0.0001
474 HAND FRACTURE 1 0.0001
475 CARDIOGENIC SHOCK 2 0.0001
476 ORAL DISORDER 1 0.0001
477 MOUTH HAEMORRHAGE 1 0.0001
478 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
479 URINARY INCONTINENCE 4 0.0001
480 SKIN HAEMORRHAGE 2 0.0001
481 COLITIS ULCERATIVE 6 0.0001
482 IMMUNODEFICIENCY 2 0.0001
483 THERAPY NON-RESPONDER 6 0.0001
484 PAROSMIA 1 0.0001
485 PRODUCT QUALITY ISSUE 18 0.0001
486 APHASIA 4 0.0001
487 OSTEOPENIA 2 0.0001
488 HEPATOCELLULAR CARCINOMA 1 0.0001
489 AORTIC ANEURYSM 1 0.0001
490 VERTIGO 8 0.0001
491 DRUG DISPENSING ERROR 2 0.0001
492 INSURANCE ISSUE 2 0.0001
493 TINNITUS 6 0.0001
494 PROCEDURAL COMPLICATION 1 0.0001
495 ASTHENIA 49 0.0001
496 RENAL FAILURE CHRONIC 1 0.0001
497 PHARYNGEAL OEDEMA 2 0.0001
498 ATRIOVENTRICULAR BLOCK 1 0.0001
499 MUSCULOSKELETAL CHEST PAIN 2 0.0001
500 ANKLE FRACTURE 2 0.0001
501 APHTHOUS ULCER 1 0.0001
502 HAEMORRHAGIC STROKE 1 0.0001
503 HAEMATOCHEZIA 7 0.0001
504 FURUNCLE 1 0.0001
505 NASAL DISCOMFORT 1 0.0001
506 RENAL CYST 1 0.0001
507 ULCER 2 0.0001
508 PRODUCT STORAGE ERROR 11 0.0001
509 GINGIVAL PAIN 1 0.0001
510 MOVEMENT DISORDER 4 0.0001
511 PERIPHERAL SWELLING 19 0.0001
512 DEEP VEIN THROMBOSIS 8 0.0001
513 BACK DISORDER 2 0.0001
514 SHOCK HAEMORRHAGIC 1 0.0001
515 MULTIPLE FRACTURES 2 0.0001
516 EYE IRRITATION 7 0.0001
517 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
518 AGEUSIA 3 0.0001
519 SKIN DISORDER 4 0.0001
520 URINARY RETENTION 4 0.0001
521 HAEMODIALYSIS 1 0.0001
522 DRUG USE DISORDER 1 0.0001
523 OROPHARYNGEAL PAIN 11 0.0001
524 INFUSION SITE ERYTHEMA 1 0.0001
525 SKIN PLAQUE 1 0.0001
526 UTERINE PERFORATION 1 0.0001
527 HEMIPARESIS 2 0.0001
528 SWELLING 11 0.0001
529 PNEUMONIA 38 0.0001
530 GASTRIC DISORDER 4 0.0001
531 IRRITABILITY 7 0.0001
532 ANURIA 1 0.0001
533 HYPOACUSIS 5 0.0001
534 NIGHTMARE 4 0.0001
535 PAIN IN EXTREMITY 34 0.0001
536 SKIN SWELLING 1 0.0001
537 NAIL DISORDER 1 0.0001
538 GROIN PAIN 1 0.0001
539 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
540 FEELING ABNORMAL 27 0.0001
541 THIRST 2 0.0001
542 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
543 PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0001
544 FEAR 3 0.0001
545 DISTURBANCE IN ATTENTION 6 0.0001
546 DRY MOUTH 9 0.0001
547 GASTROENTERITIS VIRAL 2 0.0001
548 CRYING 4 0.0001
549 EXOSTOSIS 1 0.0001
550 SKIN DISCOLOURATION 5 0.0001
551 INCREASED TENDENCY TO BRUISE 1 0.0001
552 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
553 HYPERHIDROSIS 14 0.0001
554 OVARIAN CANCER 1 0.0001
555 NERVE COMPRESSION 1 0.0001
556 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
557 MENTAL STATUS CHANGES 3 0.0001
558 CHEST PAIN 20 0.0001
559 CHEST DISCOMFORT 11 0.0001
560 BLOOD CHOLESTEROL INCREASED 5 0.0001
561 ERYTHEMA MULTIFORME 1 0.0001
562 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
563 BLOOD GLUCOSE INCREASED 20 0.0001
564 SPINAL DISORDER 1 0.0001
565 ARRHYTHMIA 5 0.0001
566 PRODUCT PACKAGING ISSUE 1 0.0001
567 FEELING JITTERY 2 0.0001
568 RED BLOOD CELL COUNT DECREASED 3 0.0001
569 CONVULSION 6 0.0001
570 DRUG PRESCRIBING ERROR 2 0.0001
571 ACUTE RESPIRATORY FAILURE 2 0.0001
572 HYPERCHOLESTEROLAEMIA 1 0.0001
573 DRUG INTOLERANCE 10 0.0001
574 COUGH 29 0.0001
575 HAEMORRHOIDS 2 0.0001
576 SKIN FISSURES 2 0.0001
577 NASAL CONGESTION 6 0.0001
578 COELIAC DISEASE 1 0.0001
579 RENAL TUBULAR NECROSIS 1 0.0001
580 VITREOUS FLOATERS 1 0.0001
581 LABORATORY TEST ABNORMAL 3 0.0001
582 HOSPICE CARE 1 0.0001
583 EMBEDDED DEVICE 1 0.0001
584 DISORIENTATION 4 0.0001
585 BLADDER DISORDER 1 0.0001
586 FATIGUE 78 0.0001
587 SALIVARY HYPERSECRETION 1 0.0001
588 THROMBOSIS 8 0.0001
589 PRODUCT PHYSICAL ISSUE 2 0.0001
590 PRODUCT ADMINISTRATION ERROR 2 0.0001
591 STOMATITIS 6 0.0001
592 DISCOMFORT 6 0.0001
593 FLUID RETENTION 5 0.0001
594 INJURY ASSOCIATED WITH DEVICE 2 0.0001
595 SUBARACHNOID HAEMORRHAGE 1 0.0001
596 FEELING HOT 6 0.0001
597 SINUSITIS 10 0.0001
598 INITIAL INSOMNIA 1 0.0001
599 THERAPY CESSATION 5 0.0001
600 OSTEOPOROSIS 4 0.0001
601 MUSCULAR WEAKNESS 11 0.0001
602 DIARRHOEA 62 0.0001
603 PULMONARY HYPERTENSION 2 0.0001
604 PARAESTHESIA 15 0.0001
605 ANXIETY 27 0.0001
606 JOINT DISLOCATION 1 0.0001
607 DEPRESSED MOOD 5 0.0001
608 MYALGIA 16 0.0001
609 JOINT INJURY 2 0.0001
610 IMPAIRED WORK ABILITY 2 0.0001
611 BODY HEIGHT DECREASED 1 0.0001
612 BREAST CANCER METASTATIC 1 0.0001
613 UNEVALUABLE EVENT 7 0.0001
614 PHARYNGITIS STREPTOCOCCAL 1 0.0001
615 RASH PRURITIC 5 0.0001
616 BIPOLAR DISORDER 1 0.0001
617 BACK INJURY 1 0.0001
618 CHOLELITHIASIS 3 0.0001
619 EYE DISORDER 3 0.0001
620 EXPIRED PRODUCT ADMINISTERED 3 0.0001
621 VENTRICULAR FIBRILLATION 1 0.0001
622 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
623 NECK PAIN 5 0.0001
624 ORAL PAIN 2 0.0001
625 WEIGHT INCREASED 20 0.0001
626 THROAT IRRITATION 4 0.0001
627 ARTHRITIS 7 0.0001
628 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
629 ANGER 3 0.0001
630 MYOCARDIAL ISCHAEMIA 1 0.0001
631 HEADACHE 55 0.0001
632 SCAB 1 0.0001
633 CHOLECYSTECTOMY 1 0.0001
634 NEPHROLITHIASIS 4 0.0001
635 NEOPLASM 1 0.0001
636 ADVERSE EVENT 8 0.0001
637 INSOMNIA 23 0.0001
638 MADAROSIS 1 0.0001
639 EYELID OEDEMA 1 0.0001
640 WEIGHT DECREASED 24 0.0001
641 DYSPHONIA 5 0.0001
642 PALPITATIONS 10 0.0001
643 BONE PAIN 5 0.0001
644 INFLUENZA LIKE ILLNESS 7 0.0001
645 MALAISE 37 0.0001
646 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
647 OCULAR HYPERAEMIA 4 0.0001
648 BACTERAEMIA 1 0.0001
649 PRODUCT PRESCRIBING ERROR 2 0.0001
650 JOINT SWELLING 10 0.0001
651 ABDOMINAL PAIN UPPER 17 0.0001
652 ILL-DEFINED DISORDER 5 0.0001
653 ABDOMINAL PAIN 19 0.0001
654 ENCEPHALOPATHY 2 0.0001
655 DYSPEPSIA 8 0.0001
656 SMALL INTESTINAL OBSTRUCTION 1 0.0001
657 SPINAL OPERATION 1 0.0001
658 TENDON RUPTURE 1 0.0001
659 HYPERSENSITIVITY 15 0.0001
660 DYSGEUSIA 6 0.0001
661 CYST 1 0.0001
662 DYSPNOEA EXERTIONAL 3 0.0001
663 ABDOMINAL PAIN LOWER 2 0.0001
664 GASTRIC CANCER 2 0.0001
665 CARDIOVASCULAR DISORDER 2 0.0001
666 FLUSHING 8 0.0001
667 NAUSEA 62 0.0001
668 HYPOPHAGIA 2 0.0001
669 GENITAL HAEMORRHAGE 1 0.0001
670 DYSPNOEA 44 0.0001
671 INFUSION SITE PAIN 1 0.0001
672 DECREASED APPETITE 18 0.0001
673 RHINORRHOEA 5 0.0001
674 CEREBROVASCULAR ACCIDENT 13 0.0001
675 PLATELET COUNT INCREASED 1 0.0001
676 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
677 NERVOUSNESS 4 0.0001
678 DEAFNESS 2 0.0001
679 ANHEDONIA 2 0.0001
680 ANKYLOSING SPONDYLITIS 1 0.0001
681 SARS-COV-2 TEST POSITIVE 1 0.0001
682 PANCREATITIS 4 0.0001
683 DYSMENORRHOEA 1 0.0001
684 EAR INFECTION 2 0.0001
685 HAIR TEXTURE ABNORMAL 1 0.0001
686 JOINT RANGE OF MOTION DECREASED 1 0.0001
687 SOMNOLENCE 15 0.0001
688 EXTRA DOSE ADMINISTERED 3 0.0001
689 DYSKINESIA 3 0.0001
690 OEDEMA 4 0.0001
691 HYPOAESTHESIA 11 0.0001
692 ACUTE HEPATIC FAILURE 1 0.0001
693 TREATMENT NONCOMPLIANCE 4 0.0001
694 CORONARY ARTERY OCCLUSION 1 0.0001
695 SKIN LESION 2 0.0001
696 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
697 ABNORMAL DREAMS 2 0.0001
698 DIVERTICULITIS 2 0.0001
699 HYPOMAGNESAEMIA 1 0.0001
700 HUNGER 1 0.0001
701 SEPSIS 8 0.0001
702 COORDINATION ABNORMAL 1 0.0001
703 WOUND 2 0.0001
704 CARPAL TUNNEL SYNDROME 1 0.0001
705 BURNING SENSATION 5 0.0001
706 BLISTER 4 0.0001
707 OXYGEN SATURATION DECREASED 4 0.0001
708 BLINDNESS UNILATERAL 1 0.0001
709 PAIN IN JAW 2 0.0001
710 FLATULENCE 4 0.0001
711 DIALYSIS 1 0.0001
712 BRONCHOSPASM 1 0.0001
713 PARALYSIS 1 0.0001
714 ANGINA PECTORIS 2 0.0001
715 MOBILITY DECREASED 5 0.0001
716 IMPAIRED QUALITY OF LIFE 1 0.0001
717 BALANCE DISORDER 6 0.0001
718 DRUG INTERACTION 11 0.0001
719 PARAESTHESIA ORAL 1 0.0001
720 HYPERTHYROIDISM 1 0.0001
721 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
722 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
723 RESPIRATORY FAILURE 5 0.0001
724 ASCITES 2 0.0001
725 GAIT DISTURBANCE 13 0.0001
726 WHEEZING 4 0.0001
727 COLON CANCER 1 0.0001
728 GASTROINTESTINAL DISORDER 6 0.0001
729 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
730 HOT FLUSH 5 0.0001
731 TREMOR 11 0.0001
732 OEDEMA PERIPHERAL 8 0.0001
733 MEMORY IMPAIRMENT 9 0.0001
734 HIP ARTHROPLASTY 1 0.0001
735 PRODUCT DOSE OMISSION ISSUE 19 0.0001
736 COGNITIVE DISORDER 3 0.0001
737 BRAIN FOG 1 0.0001
738 PAIN 39 0.0001
739 PNEUMOTHORAX 1 0.0001
740 RESPIRATORY TRACT CONGESTION 1 0.0001
741 CYSTITIS 2 0.0001
742 RASH ERYTHEMATOUS 3 0.0001
743 MOOD SWINGS 2 0.0001
744 SCIATICA 1 0.0001
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
746 HIP FRACTURE 2 0.0001
747 MUSCLE TIGHTNESS 1 0.0001
748 VOMITING 29 0.0001
749 AMNESIA 4 0.0001
750 IMPAIRED HEALING 2 0.0001
751 PHOTOSENSITIVITY REACTION 1 0.0001
752 DRUG DOSE OMISSION 10 0.0001
753 DRY EYE 3 0.0001
754 DRY SKIN 8 0.0001
755 NEOPLASM MALIGNANT 4 0.0001
756 URTICARIA 10 0.0001
757 RASH 26 0.0001
758 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
759 HAEMOGLOBIN DECREASED 6 0.0001
760 EMOTIONAL DISTRESS 7 0.0001
761 ABDOMINAL DISTENSION 6 0.0001
762 PRURITUS 22 0.0001
763 RASH MACULAR 2 0.0001
764 DEVICE USE ISSUE 1 0.0001
765 SYRINGE ISSUE 1 0.0001
766 DEPRESSION 13 0.0001
767 INTENTIONAL PRODUCT MISUSE 5 0.0001
768 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
769 INJURY 4 0.0001
770 DERMATITIS ATOPIC 3 0.0001
771 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
772 GALLBLADDER DISORDER 1 0.0001
773 THERAPY INTERRUPTED 4 0.0001
774 COMPLICATION OF DEVICE REMOVAL 1 0.0001
775 LEUKOCYTOSIS 1 0.0001
776 BONE DISORDER 1 0.0001
777 PANIC ATTACK 2 0.0001
778 BLOOD GLUCOSE ABNORMAL 1 0.0001
779 INJECTION SITE MASS 2 0.0001
780 BACTERIAL INFECTION 1 0.0001
781 MIDDLE INSOMNIA 1 0.0001
782 PRODUCT USE ISSUE 10 0.0001
783 PHOTOPHOBIA 1 0.0001
784 COLITIS 2 0.0001
785 BLOOD URINE PRESENT 1 0.0001
786 MUSCULOSKELETAL DISORDER 1 0.0001
787 DIABETES MELLITUS 4 0.0001
788 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
789 INCREASED APPETITE 1 0.0001
790 HERPES ZOSTER 3 0.0001
791 POST PROCEDURAL COMPLICATION 1 0.0001
792 LOWER LIMB FRACTURE 1 0.0001
793 CONTUSION 5 0.0001
794 GLAUCOMA 1 0.0001
795 BACK PAIN 12 0.0001
796 MYOCARDIAL INFARCTION 9 0.0001
797 ATRIAL FIBRILLATION 5 0.0001
798 CHOKING 1 0.0001
799 SURGERY 3 0.0001
800 KIDNEY INFECTION 1 0.0001
801 ALOPECIA 10 0.0001
802 DRUG INEFFECTIVE 67 0.0001
803 DISABILITY 1 0.0001
804 ARTHRALGIA 21 0.0001
805 FULL BLOOD COUNT DECREASED 1 0.0000
806 CONFUSIONAL STATE 8 0.0000
807 THERAPEUTIC RESPONSE DECREASED 3 0.0000
808 CONDITION AGGRAVATED 15 0.0000
809 FEEDING DISORDER 1 0.0000
810 TASTE DISORDER 1 0.0000
811 BODY TEMPERATURE INCREASED 1 0.0000
812 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
813 PRODUCT PREPARATION ERROR 1 0.0000
814 RIB FRACTURE 1 0.0000
815 CARDIAC ARREST 4 0.0000
816 PERITONITIS 1 0.0000
817 ROAD TRAFFIC ACCIDENT 2 0.0000
818 DERMATITIS 1 0.0000
819 KNEE ARTHROPLASTY 1 0.0000
820 MOUTH ULCERATION 1 0.0000
821 SKIN EXFOLIATION 4 0.0000
822 RENAL FAILURE ACUTE 2 0.0000
823 URINARY TRACT INFECTION 8 0.0000
824 IRRITABLE BOWEL SYNDROME 1 0.0000
825 LIVER FUNCTION TEST INCREASED 1 0.0000
826 POOR QUALITY SLEEP 1 0.0000
827 PRURITUS GENERALISED 1 0.0000
828 FAECES DISCOLOURED 1 0.0000
829 SWELLING FACE 3 0.0000
830 SEPTIC SHOCK 2 0.0000
831 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
832 APPLICATION SITE PAIN 1 0.0000
833 STEVENS-JOHNSON SYNDROME 1 0.0000
834 TOOTH DISORDER 1 0.0000
835 INFLUENZA 5 0.0000
836 GLOSSODYNIA 1 0.0000
837 RASH PAPULAR 1 0.0000
838 CHROMATURIA 1 0.0000
839 APPLICATION SITE PRURITUS 1 0.0000
840 PRODUCT AVAILABILITY ISSUE 1 0.0000
841 ERYTHEMA 9 0.0000
842 MUSCLE TWITCHING 1 0.0000
843 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
844 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
845 FALL 14 0.0000
846 COMA 2 0.0000
847 ANAEMIA 8 0.0000
848 MIGRAINE 4 0.0000
849 BLOOD GLUCOSE DECREASED 2 0.0000
850 DIABETIC KETOACIDOSIS 1 0.0000
851 LOCALISED INFECTION 1 0.0000
852 MENTAL IMPAIRMENT 1 0.0000
853 HYPOGLYCAEMIA 2 0.0000
854 NEURALGIA 1 0.0000
855 AGITATION 3 0.0000
856 VISUAL IMPAIRMENT 5 0.0000
857 HALLUCINATION 3 0.0000
858 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
859 ACNE 3 0.0000
860 PRODUCT COMPLAINT 1 0.0000
861 HEPATITIS 1 0.0000
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
863 ANAPHYLACTIC SHOCK 1 0.0000
864 INFLAMMATION 2 0.0000
865 UNRESPONSIVE TO STIMULI 1 0.0000
866 EXPOSURE VIA SKIN CONTACT 1 0.0000
867 DIPLOPIA 1 0.0000
868 RESPIRATORY TRACT INFECTION 1 0.0000
869 MUSCULOSKELETAL PAIN 2 0.0000
870 SPEECH DISORDER 2 0.0000
871 APPLICATION SITE ERYTHEMA 1 0.0000
872 JOINT STIFFNESS 1 0.0000
873 GASTRITIS 1 0.0000
874 NASOPHARYNGITIS 7 0.0000
875 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
876 CARDIAC FAILURE CONGESTIVE 3 0.0000
877 MENSTRUATION IRREGULAR 1 0.0000
878 PAIN OF SKIN 1 0.0000
879 LIMB INJURY 1 0.0000
880 PALLOR 1 0.0000
881 PNEUMONITIS 1 0.0000
882 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
883 RESPIRATORY ARREST 1 0.0000
884 PROCEDURAL PAIN 1 0.0000
885 ARTHROPATHY 2 0.0000
886 FEELING COLD 1 0.0000
887 ABDOMINAL DISCOMFORT 6 0.0000
888 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
889 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
890 HYPERSOMNIA 1 0.0000
891 PRODUCT SUBSTITUTION ISSUE 2 0.0000
892 LIVER FUNCTION TEST ABNORMAL 1 0.0000
893 NEEDLE ISSUE 1 0.0000
894 MUSCULOSKELETAL STIFFNESS 3 0.0000
895 CHILLS 4 0.0000
896 ACUTE MYOCARDIAL INFARCTION 1 0.0000
897 TACHYCARDIA 3 0.0000
898 RESPIRATORY DISORDER 1 0.0000
899 HEPATIC FAILURE 1 0.0000
900 LACRIMATION INCREASED 1 0.0000
901 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
902 CORONARY ARTERY DISEASE 1 0.0000
903 INJECTION SITE PAIN 10 0.0000
904 DRUG ADMINISTRATION ERROR 1 0.0000
905 HOSPITALISATION 5 0.0000
906 LIMB DISCOMFORT 1 0.0000
907 SWOLLEN TONGUE 1 0.0000
908 DRUG-INDUCED LIVER INJURY 1 0.0000
909 INCORRECT DOSE ADMINISTERED 7 0.0000
910 STAPHYLOCOCCAL INFECTION 1 0.0000
911 DEVICE DIFFICULT TO USE 2 0.0000
912 INFUSION RELATED REACTION 2 0.0000
913 GAIT INABILITY 1 0.0000
914 EYE PRURITUS 1 0.0000
915 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
916 HEPATIC ENZYME INCREASED 2 0.0000
917 HAEMATURIA 1 0.0000
918 INJECTION SITE REACTION 2 0.0000
919 DEVICE USE ERROR 1 0.0000
920 NEOPLASM PROGRESSION 1 0.0000
921 HAEMORRHAGE 3 0.0000
922 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
923 CEREBRAL HAEMORRHAGE 1 0.0000
924 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
925 DRUG EFFECT INCOMPLETE 1 0.0000
926 HYPERGLYCAEMIA 1 0.0000
927 EPISTAXIS 2 0.0000
928 DEATH 23 0.0000
929 ASTHMA 3 0.0000
930 RHEUMATOID ARTHRITIS 3 0.0000
931 OFF LABEL USE 23 0.0000
932 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
933 PYREXIA 9 0.0000
934 SEIZURE 3 0.0000
935 DRUG DOSE OMISSION BY DEVICE 2 0.0000
936 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
937 ABNORMAL BEHAVIOUR 1 0.0000
938 INJECTION SITE BRUISING 2 0.0000
939 ABORTION SPONTANEOUS 1 0.0000
940 CARDIAC FAILURE 2 0.0000
941 PSORIATIC ARTHROPATHY 1 0.0000
942 DEVICE BREAKAGE 1 0.0000
943 BLINDNESS 1 0.0000
944 NEUTROPHIL COUNT DECREASED 1 0.0000
945 LUNG NEOPLASM MALIGNANT 1 0.0000
946 TREATMENT FAILURE 2 0.0000
947 RHABDOMYOLYSIS 1 0.0000
948 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
949 CARDIO-RESPIRATORY ARREST 1 0.0000
950 TOXICITY TO VARIOUS AGENTS 4 0.0000
951 OSTEOARTHRITIS 1 0.0000
952 RECTAL HAEMORRHAGE 1 0.0000
953 DEVICE LEAKAGE 1 0.0000
954 VAGINAL HAEMORRHAGE 1 0.0000
955 PSORIASIS 3 0.0000
956 LIVER DISORDER 1 0.0000
957 PULMONARY OEDEMA 1 0.0000
958 DEVICE ISSUE 2 0.0000
959 SUICIDAL IDEATION 2 0.0000
960 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
961 CARDIAC DISORDER 2 0.0000
962 PULMONARY EMBOLISM 2 0.0000
963 MULTIPLE SCLEROSIS 1 0.0000
964 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
965 ILLNESS 2 0.0000
966 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
967 ECZEMA 1 0.0000
968 BRADYCARDIA 1 0.0000
969 DRUG EFFECT DECREASED 1 0.0000
970 EYE PAIN 1 0.0000
971 DISEASE PROGRESSION 2 0.0000
972 PLEURAL EFFUSION 1 0.0000
973 FEBRILE NEUTROPENIA 1 0.0000
974 INJECTION SITE PRURITUS 1 0.0000
975 NEUTROPENIA 2 0.0000
976 DEVICE MALFUNCTION 1 0.0000
977 SKIN BURNING SENSATION 1 0.0000
978 UNDERDOSE 1 0.0000
979 INJECTION SITE HAEMORRHAGE 1 0.0000
980 PROSTATE CANCER 1 0.0000
981 COVID-19 2 0.0000
982 ADVERSE DRUG REACTION 1 0.0000
983 NO ADVERSE EVENT 2 0.0000
984 BREAST CANCER 1 0.0000
985 DYSPHAGIA 1 0.0000
986 PLATELET COUNT DECREASED 1 0.0000
987 OVERDOSE 2 0.0000
988 THROMBOCYTOPENIA 1 0.0000
989 INFECTION 1 0.0000